Loading clinical trials...
Loading clinical trials...
Multi-tracer PET Assessment of Response in Various Malignancies in Investigational and Recently Approved Therapeutic Agents
Conditions
Interventions
[F-18]fluorodeoxyglucose
[F-18]fluorothymidine
+2 more
Locations
1
United States
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, United States
Start Date
February 2, 2011
Primary Completion Date
December 12, 2015
Completion Date
April 8, 2016
Last Updated
April 17, 2024
NCT04693377
NCT06500455
NCT07487883
NCT04654208
NCT05863195
NCT07131007
Lead Sponsor
University of Utah
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions